Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

Danaher Corp. Stock

Price
Target price
€168.45

€168.45

-0.530%
-0.9
-0.530%
€209.43
 
24.07.26 / Tradegate WKN: 866197 / Symbol: DHR / Name: Danaher / Stock / Machinery, Equipment & Components / Large Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Danaher Corp. in the next few years
Wizard

Danaher Corp. Stock

Danaher Corp. shows a slight decrease today, losing -€0.900 (-0.530%) compared to yesterday.
The stock is an absolute favorite of our community with 45 Buy predictions and no Sell predictions.
As a result the target price of 209 € shows a positive potential of 24.07% compared to the current price of 168.45 € for Danaher Corp..
For the coming years our community has positive and negative things to say abot the Danaher Corp. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Debt" there were negative voices in the community.
What does Danaher do?

Pros and Cons of Danaher Corp. in the next few years

Pros
?
B****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

Performance of Danaher Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Danaher Corp. -0.530% -5.418% 1.232% -2.359% -14.039% -27.766% -31.939%
Enovis Corp. 0.000% -3.390% 21.277% -0.870% 0.000% -60.000% -80.000%
W.W. Grainger Inc. -0.670% -0.246% 2.703% 35.957% 39.418% 74.813% 213.564%
IDEX Corp. 1.180% -2.350% 0.463% 24.713% 27.689% 2.144% 1.192%

sharewise BeanCounterBot AI-generated

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2025-04-26

Danaher Corp's current financial position shows:

Key findings: * Revenue remained relatively stable compared to the same quarter last year ($5.741 billion in Q2 2024) * Net profit decreased by 12.3% compared to Q2 2024 ($1.088 billion vs $1.242 billion) * Cash and cash equivalents decreased to $1.993 billion from $2.078 billion at the end of 2024

Overall financial trend: Mixed

Show more

Comments

Danaher (DHR) had its "buy" rating reaffirmed by Deutsche Bank Aktiengesellschaft.
Ratings data for DHR provided by MarketBeat
Show more

Deutsche Bank Aktiengesellschaft 
0
Report Share
22.07.26 Buy 9.56%

Danaher (DHR) had its "buy" rating reaffirmed by TD Cowen.
Ratings data for DHR provided by MarketBeat
Show more

TD Cowen 
0
Report Share
22.07.26 Buy 9.56%

Danaher (DHR) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Ratings data for DHR provided by MarketBeat
Show more

Royal Bank of Canada 
0
Report Share
22.07.26 Buy 7.91%
Show more
Not a member yet? Sign up for free!

News

Here's Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity: https://g.foolcdn.com/editorial/images/880464/a-scientist-uses-a-pipette-to-work-with-medical-samples-1200x675-128554e.jpg
Here's Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity

Shareholders in biotechnology, life sciences, and diagnostics solutions company Danaher (NYSE: DHR) have had an interesting week. Their stock crashed early in the week on the release of its

TheMotleyFool 
0 24.07.26
Danaher Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, Metal fabrication, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://img.midjourneyapi.xyz/temp/568784d0-c41a-4663-ab01-91f29a370903.png
Danaher Q2 Earnings Call Highlights

Key Points

MarketBeat 
0 21.07.26
Danaher Is Down 22% This Year. Is the Masimo Acquisition the Entry Point Investors Have Been Waiting for?: https://g.foolcdn.com/editorial/images/874976/adaptimmune.jpg
Danaher Is Down 22% This Year. Is the Masimo Acquisition the Entry Point Investors Have Been Waiting for?

Danaher (NYSE: DHR) focuses on life sciences, diagnostics, and industrial solutions for healthcare and sells specialized equipment, software, consumables, and reagents used by pharmaceutical

TheMotleyFool 
0 24.06.26